ArticleNature communications2026
Deprotonation-mediated vitrification of organic-inorganic hybrid perovskites.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Glasses made from organic-inorganic hybrid perovskites are emerging non-crystalline semiconducting materials whose versatile composition and exceptional processability allow for manifold applications. The current melt-quenching approaches are compatible to only few perovskite crystals, as most undergo irreversible decomposition prior to melting. Herein, we report a general flux-mediated approach to produce a library of high-quality perovskite glasses with different organic molecules, metal centers, and framework dimensionality. We show that the partial deprotonation of organic moiety by alkali metal hydroxide flux modulates the intermolecular interactions in perovskites, and activates the flow unit, which depresses the fusion temperature ranging 21-77 °C with flux ratio <1.1 wt%. More critically, the utilization of hydroxide flux creates a large melt window, and enables the thermal vitrification of many inherently non-meltable systems, such as (BA)
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.